Akeso, Inc. (AKESF)
OTCMKTS · Delayed Price · Currency is USD
16.20
+0.09 (0.59%)
Oct 16, 2025, 9:30 AM EDT
Akeso Market Cap
Akeso has a market cap or net worth of $14.53 billion as of October 17, 2025. Its market cap has increased by 114.92% in one year.
Market Cap
14.53B
Enterprise Value
14.15B
Revenue
350.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
$16.20
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 2.39B to 14.53B, an increase of 507.40%. That is a compound annual growth rate of 38.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 15.15B | 115.97% |
| Dec 31, 2024 | 7.01B | 40.41% |
| Dec 29, 2023 | 5.00B | 7.71% |
| Dec 30, 2022 | 4.64B | 30.19% |
| Dec 31, 2021 | 3.56B | -7.64% |
| Dec 31, 2020 | 3.86B | 61.23% |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 702.42M |
| Elite Pharmaceuticals | 652.54M |
| Veradigm | 500.94M |
| Nika Pharmaceuticals | 495.49M |
| The Greater Cannabis Company | 404.95M |
| Northwest Biotherapeutics | 347.69M |
| CytoDyn | 332.83M |
| Silence Therapeutics | 301.35M |